280
Participants
Start Date
July 28, 2023
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
VVD-130037
Oral tablets
Docetaxel
IV infusion
Paclitaxel
IV infusion
RECRUITING
NEXT Virginia, Fairfax
RECRUITING
Mayo Clinic Jacksonville, Jacksonville
RECRUITING
Moffitt Cancer Center, Tampa
RECRUITING
Florida Cancer Specialists, Sarasota
RECRUITING
Sarah Cannon Research Institute, Nashville
RECRUITING
Mayo Clinic Rochester, Rochester
RECRUITING
NEXT Dallas, Irving
RECRUITING
MDACC, Houston
NOT_YET_RECRUITING
National Cancer Center, Goyang
NOT_YET_RECRUITING
Gachon University Gil Medical Center, Incheon
NOT_YET_RECRUITING
Seoul National University; Bundang Hospital, Seongnam
NOT_YET_RECRUITING
Asan Medical Center, Seoul
NOT_YET_RECRUITING
Samsung Medical Center, Seoul
NOT_YET_RECRUITING
Seoul National University Hospital, Seoul
NOT_YET_RECRUITING
Severance Hospital; Yonsei University Health System, Seoul
NOT_YET_RECRUITING
The Catholic University of Korea, St. Vincent's Hospital, Suwon
RECRUITING
Hospital Vall d'Hebron, Barcelona
RECRUITING
START Barcelona Hospital HM Nou Delfos, Barcelona
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
NOT_YET_RECRUITING
Hospital Universitario Ramon y Cajal, Madrid
RECRUITING
NEXT Madrid, Madrid
RECRUITING
START Madrid CIOCC, Madrid
RECRUITING
Start Madrid-FJD, Hospital Fundacion Jimenez Diaz, Madrid
NOT_YET_RECRUITING
Clinica Universitaria de Navarra, Pamplona
RECRUITING
Hospital Clinico Universitario de Valencia, Valencia
Vividion Therapeutics, Inc.
INDUSTRY